Status:
UNKNOWN
Follow up After TACE by Elastography and Color Doppler.
Lead Sponsor:
Assiut University
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
Brief Summary
To determine accuracy of elastography and color Doppler in follow up of patients with HCC after TACE comparing with modified RECIST criteria.
Detailed Description
The incidence of liver cancer is one of the highest in the world. In Egypt HCC is the forth common cancer and represents up to 90% of all liver malignancies. Where it is responsible for 33.63% and 13....
Eligibility Criteria
Inclusion
- All patients with hepatocellular carcinoma underwent TACE in South Egypt cancer institute.
Exclusion
- Patients with liver metastases.
- Patients with hepatic or perihepatic inflammations.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06070623
Start Date
November 1 2023
End Date
December 31 2025
Last Update
October 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.